IP Library Granted Patent US 9,650,667
Granted Patent B2
US 9,650,667 · App. 14/508,508 · Granted May 16, 2017

Method for reducing adapter-dimer formation

Inventors: Larry A. McReynolds (Beverly, MA); Daniela Munafo (South Hamilton, MA)
Assignee: New England Biolabs, Inc.
C12Q1/6855C12N15/1065C12N15/1096C12Q1/6832C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,667
App. No.
14/508,508
Granted
May 16, 2017
Kind
B2
Abstract

Methods are provided for ligating a 3′ adapter and a 5′ adapter to a target polynucleotide so as to avoid adapter dimer formation. Embodiments of the methods include adding a blocking oligonucleotide after the first ligation in which a 3′ adapter is ligated to the target polynucleotide so that the blocking oligonucleotide is capable of hybridizing to excess 3′ adapter and the ligated 3′ adapter. Subsequently, a 5′ adapter is ligated to the target polynucleotide thus avoiding adapter dimer formation.

Claims (35)

1. A kit comprising:

(a) a 3′ adapter oligonucleotide having a non-natural 3′ end that prevents ligation of the 3′ end of the 3′ adapter oligonucleotide to another polynucleotide;

(b) a blocking oligonucleotide that has a 3′ hydroxyl group and at least 10 nucleotides of complementary to the 3′ adapter, wherein the blocking oligonucleotide:

hybridizes to the 3′ adaptor oligonucleotide to produce a duplex having a blunt end comprising the 3′ hydroxyl group of the blocking oligonucleotide; and

primes cDNA synthesis of an RNA polynucleotide when the 3′ adaptor oligonucleotide is ligated to the 3′ end of the RNA polynucleotide; and

(c) a buffer comprising a non-naturally occurring buffering agent.

2. A kit according to claim 1 , further comprising a first ligase.

3. A kit according to claim 1 further comprising a second ligase.

4. A kit according to claim 3 , wherein the second ligase is a T4 mutant ligase.

5. A kit according to claim 1 , wherein the blocking oligonucleotide is a DNA.

6. A kit according to claim 1 further comprising a 5′ adapter.

7. A kit according to claim 1 , further comprising a reverse transcriptase.

8. A kit according to claim 1 , wherein the 3′ adapter has a length of 10-50 nucleotides.

9. A kit according to claim 1 , wherein the 3′ adapter is pre-adenylated.

10. A reaction mixture, comprising:

(a) a 3′ adapter oligonucleotide having a non-natural 3′ end that prevents ligation of the 3′ end of the 3′ adapter oligonucleotide to another polynucleotide ;

(b) a buffer comprising a non-naturally occurring buffering agent; and

(c) a polynucleotide; and

(d) a blocking oligonucleotide has a 3′ hydroxyl group and at least 10 base pairs of complementary to the 3′ adapter oligonucleotide, wherein:

i. some of the 3′ adapter oligonucleotide is ligated to the 3′ end of the polynucleotide and some of the 3′ adapter oligonucleotide is not ligated to the 3′ end of the polynucleotide; and

ii. the blocking oligonucleotide is hybridized to at least the 3′ adapter oligonucleotide that is not ligated to the 3′ end of the polynucleotide to produce a duplex having a blunt end comprising the 3′ hydroxyl group of the blocking oligonucleotide.

11. A reaction mixture according to claim 10 , wherein the polynucleotide is an RNA and the 3′ adapter is a DNA.

12. A reaction mixture according to claim 10 , further comprising a 5′ adapter ligated to the polynucleotide.

13. A reaction mixture according to claim 10 , further comprising a reverse transcriptase.

14. A reaction mixture according to claim 10 , wherein the polynucleotide is a member of a polynucleotide library wherein the polynucleotides in the library are ligated to 3′ adapters.

15. A reaction mixture according to claim 10 , wherein the 3′ adapters contain a barcode.

16. A reaction mixture comprising:

(a) a 3′ adapter oligonucleotide having a non-natural 3′ end that prevents ligation of the 3′ end of the 3′ adapter oligonucleotide to another polynucleotide;

(b) a buffer comprising a non-naturally occurring buffering agent; and

(c) a polynucleotide; and

(d) a blocking oligonucleotide has a 3′ hydroxyl group and at least 10 nucleotides of complementary to the 3′ adapter oligonucleotide, wherein:

i. some of the 3′ adapter oligonucleotide is ligated to the 3′ end of the polynucleotide and some of the 3′ adapter oligonucleotide is not ligated to the 3′ end of the polynucleotide; and

ii. the blocking oligonucleotide is hybridized to at least the 3′ adapter oligonucleotide that is not ligated to the 3′ end of the polynucleotide,

wherein different polynucleotides ligated to a 3′ adapter are pooled from multiple samples and the blocking oligonucleotide is hybridized to excess 3′ adapter oligonucleotide.

17. A reaction mixture according to claim 10 , wherein the polynucleotide is a member of a library of polynucleotides.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2015
From: MCREYNOLDS, LARRY A.; MUNAFO, DANIELA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 035188/0027 →
Continuity (3)
Continuation 13383466
Provisional Application 61381801 · Sep 10, 2010
Related Publication 20150072870A1 · Mar 12, 2015